Cervical Neuroendocrine Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Cervical Neuroendocrine Carcinoma

subtype

Identifier: CI-CAN-00002171
Entity page: /cancer/cervical-neuroendocrine-carcinoma ↗
Edges: 21

Neighbours: 8 drugs10 trials
Drawn: 18 of 18 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Cervical Neuroendocrine Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived8 of 8
→ investigated in trials for	Cisplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Cervical Neuroendocrine Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants

Cervical Neuroendocrine Carcinoma studied in …STUDIED_INderived10 of 13show all (up to 200)
→ studied in	NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 13 trials mapped (3 active)	—	—	Cervical Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 13 trials mapped (3 active)	—	—	Cervical Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07276360Phase 2 · recruiting Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · condition mapped ALIAS · 13 trials mapped (3 active)	—	—	Cervical Small Cell Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02164461Phase 1 · completed Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer · condition mapped ALIAS · 13 trials mapped (3 active)	—	—	Cervical Small Cell Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04635956Phase 2 · unknown Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas · condition mapped ONTOLOGY_EXACT · 13 trials mapped (3 active)	—	—	Cervical Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01266447Phase 2 · completed Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer · condition mapped ALIAS · 13 trials mapped (3 active)	—	—	Cervical Small Cell Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00416455Phase 1/Phase 2 · completed Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer · condition mapped ALIAS · 13 trials mapped (3 active)	—	—	Cervical Small Cell Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00309959Phase 2 · completed ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer · condition mapped ALIAS · 13 trials mapped (3 active)	—	—	Cervical Small Cell Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00460356completed Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes · condition mapped ALIAS · 13 trials mapped (3 active)	—	—	Cervical Small Cell Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00897442completed Collecting Tumor Samples From Patients With Gynecological Tumors · condition mapped ALIAS · 13 trials mapped (3 active)	—	—	Cervical Small Cell Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →